Close

Spero Therapeutics (SPRO) SPR720 Phase 2a Clinical Trial in NTM-PD Has Been Placed on Clinical Hold by FDA

Go back to Spero Therapeutics (SPRO) SPR720 Phase 2a Clinical Trial in NTM-PD Has Been Placed on Clinical Hold by FDA

Spero Therapeutics (SPRO) Halted on LUDP, Off Lows

February 5, 2021 12:24 PM EST

Spero Therapeutics (NASDAQ: SPRO) Halted on LUDP, Off Lows

... More

Spero Therapeutics (SPRO) to Resume Trading at 8:30 a.m.

February 5, 2021 8:09 AM EST

Spero Therapeutics (NASDAQ: SPRO) to Resume Trading at 8:30 a.m.

... More